UNIVERSITY OF KANSAS MEDICAL CENTER
CoMTAD: Cognitive Monitoring during Treatment for Alzheimer disease
CoMTAD: Cognitive Monitoring during Treatment for Alzheimer disease is a funding opportunity from UNIVERSITY OF KANSAS MEDICAL CENTER, up to 589614, closing December 31, 2030.
Dec 31, 2030
(1614d left)Overview
PROJECT SUMMARY There are now anti-amyloid therapies available to slow the clinical progression of Alzheimer’s disease (AD). These therapies come with the risk of negative side-effects including amyloid related imaging abnormalities (ARIA). Little is known about acute and long-term cognitive consequences of ARIA…